|
HIC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.767300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.007700E-04 |
| Normal-vs-Stage2 |
1.082360E-02 |
| Normal-vs-Stage3 |
1.579330E-04 |
| Normal-vs-Stage4 |
3.63770000000319E-06 |
| Stage1-vs-Stage2 |
9.335600E-01 |
| Stage1-vs-Stage3 |
3.727800E-01 |
| Stage1-vs-Stage4 |
7.440300E-04 |
| Stage2-vs-Stage3 |
4.668600E-01 |
| Stage2-vs-Stage4 |
1.517760E-02 |
| Stage3-vs-Stage4 |
8.122500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.376580E-03 |
| Normal-vs-AfricanAmerican |
9.93940000000304E-05 |
| Normal-vs-Asian |
5.031900E-02 |
| Caucasian-vs-AfricanAmerican |
3.526600E-01 |
| Caucasian-vs-Asian |
8.072000E-01 |
| AfricanAmerican-vs-Asian |
9.330800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.413630E-04 |
| Normal-vs-Female |
5.103500E-03 |
| Male-vs-Female |
4.167200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.576170E-03 |
| Normal-vs-Extreme_Weight |
4.784100E-04 |
| Normal-vs-Obese |
2.399100E-03 |
| Normal-vs-Extreme_Obese |
4.478300E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.614200E-01 |
| Normal_Weight-vs-Obese |
6.066400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.020000E-01 |
| Extreme_Weight-vs-Obese |
5.119400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.181800E-01 |
| Obese-vs-Extreme_Obese |
5.503600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.498000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.517200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.649600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.280160E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.137200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.038400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.720250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.193600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.676950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.467600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.091700E-02 |
| Normal-VS-Type2 PRCC |
1.75129910573446E-11 |
| Normal-VS-KIRP CIMP |
1.60279999994462E-06 |
| Normal-VS-Unclassified PRCC |
2.339300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.61229996020751E-09 |
| Type1 PRCC-VS-KIRP CIMP |
5.782000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.117400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.122800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.584800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.530400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.85559999996843E-07 |
| Normal-vs-N1 |
1.834850E-04 |
| Normal-vs-N2 |
2.138300E-02 |
| N0-vs-N1 |
8.823600E-01 |
| N0-vs-N2 |
8.340600E-01 |
| N1-vs-N2 |
7.958400E-01 |
|
|
